Essentials: The Science & Treatment of Obsessive Compulsive Disorder (OCD)

Welcome back to Huberman Lab Essentials. I'm Andrew Huberman, professor of neurobiology and ophthalmology at Stanford, and today we're unpacking obsessive‑compulsive disorder—intrusive thoughts that collide with actions meant to ease them, which tragically end up strengthening the loop.

OCD is common—about 2.5 to 4 percent of people—and ranks among the most disabling conditions, siphoning time, attention, and performance from work, relationships, and everyday life.

Themes tend to cluster around checking, repetition, and order, which can include incompleteness, symmetry, and disgust or contamination. Depending on severity and where they show up, these patterns can overtake whole days.

Anxiety is the bridge between obsession and compulsion. Fear tracks an immediate threat; anxiety is that same bodily surge without a clear danger, and it drives the urge to ritualize.

There is a genetic contribution in roughly forty to fifty percent of cases, but it’s not destiny and it’s not the whole story.

The core circuit involves cortex, striatum, and thalamus, with the thalamic reticular nucleus acting as a gate on what reaches awareness. Imaging during contamination provocations shows this loop running hot, and when SSRIs help, activity in that loop tends to quiet—though these medications don’t work for everyone.

Diagnosis often uses the Yale‑Brown scale, which maps obsessions and compulsions and, crucially, drills down to the worst‑case fear. Naming that exact fear is key to targeting the circuit.

Cognitive behavioral therapy with exposure and response prevention trains anxiety tolerance while blocking rituals. It’s done gradually with a trained clinician, not as a do‑it‑yourself challenge.

In protocols led by Dr. Helen Blair Simpson, in‑person exposures with clear, predictable steps and ritual prevention across multiple sessions drive strong symptom drops, often within the first month. CBT outperforms placebo and SSRIs, and combining SSRIs with CBT typically doesn’t add further benefit on average, though medications can still be part of care in consultation with a physician.

Importantly, the partial success of SSRIs doesn’t prove serotonin is the cause of OCD; drugs can reduce symptoms without revealing root mechanism.

Cannabis, whether THC‑ or CBD‑dominant, shows little immediate relief for OCD symptoms compared to placebo. Transcranial magnetic stimulation can disrupt motor aspects of compulsions in some patients and looks most promising as an adjunct to behavioral or drug therapies.

Mindfulness practice can help by improving focus and adherence to CBT work rather than directly shrinking symptoms. Nutraceuticals like myo‑inositol show early signals for sleep and anxiety support, but dosing and combinations with therapies need more rigorous study.

My aim is that you understand the circuitry, why certain treatments work, and how to choose and sequence options wisely. OCD is widespread and deeply taxing; with the right tools and support, people can regain time, function, and quality of life—thank you for your interest in science.